Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anindya Dey

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Nucleic Acids Research|October 16, 2022
KRCC1, a modulator of the DNA damage responseFiifi Neizer-Ashun, Shailendra Kumar Dhar Dwivedi, Anindya Dey, et al.
Bioconjugate Chemistry|May 9, 2019
Gold Nanoparticles Disrupt Tumor Microenvironment - Endothelial Cell Cross Talk To Inhibit Angiogenic Phenotypes in VitroYushan Zhang, Xunhao Xiong, Yanyan Huai, et al.
Science Advances|September 16, 2020
Cystathione β-synthase regulates HIF-1α stability through persulfidation of PHD2Anindya Dey, Shubhangi Prabhudesai, Yushan Zhang, et al.
Genes & Diseases|September 26, 2022
Targeting BMI1 mitigates chemoresistance in ovarian cancerAnindya Dey, Shailendra Kumar Dhar Dwivedi, Lin Wang, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 2, 2018
Cystathionine β-synthase regulates mitochondrial morphogenesis in ovarian cancerPrabir Kumar Chakraborty, Brennah Murphy, Soumyajit Banerjee Mustafi, et al.
Redox Biology|November 10, 2023
A role for the cystathionine-β-synthase /H<sub>2</sub>S axis in astrocyte dysfunction in the aging brainAnindya Dey, Pijush Kanti Pramanik, Shailendra Kumar Dhar Dwivedi, et al.
Molecular Cancer Therapeutics|July 21, 2018
Inhibition of BMI1, a Therapeutic Approach in Endometrial CancerMegan Buechel, Anindya Dey, Shailendra Kumar Dhar Dwivedi, et al.
Molecular Cancer Therapeutics|November 22, 2017
Evaluating the Mechanism and Therapeutic Potential of PTC-028, a Novel Inhibitor of BMI-1 Function in Ovarian CancerAnindya Dey, Xunhao Xiong, Aleia Crim, et al.
EMBO Reports|August 28, 2020
MicroRNA-195 controls MICU1 expression and tumor growth in ovarian cancerGeeta Rao, Shailendra Kumar Dhar Dwivedi, Yushan Zhang, et al.
Materials Today (Kidlington, England)|October 3, 2022
Disabling partners in crime: Gold nanoparticles disrupt multicellular communications within the tumor microenvironment to inhibit ovarian tumor aggressivenessYushan Zhang, Chandra Kumar Elechalawar, Wen Yang, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Nucleic Acids Research|October 16, 2022
KRCC1, a modulator of the DNA damage responseFiifi Neizer-Ashun, Shailendra Kumar Dhar Dwivedi, Anindya Dey, et al.
Bioconjugate Chemistry|May 9, 2019
Gold Nanoparticles Disrupt Tumor Microenvironment - Endothelial Cell Cross Talk To Inhibit Angiogenic Phenotypes in VitroYushan Zhang, Xunhao Xiong, Yanyan Huai, et al.
Science Advances|September 16, 2020
Cystathione β-synthase regulates HIF-1α stability through persulfidation of PHD2Anindya Dey, Shubhangi Prabhudesai, Yushan Zhang, et al.
Genes & Diseases|September 26, 2022
Targeting BMI1 mitigates chemoresistance in ovarian cancerAnindya Dey, Shailendra Kumar Dhar Dwivedi, Lin Wang, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 2, 2018
Cystathionine β-synthase regulates mitochondrial morphogenesis in ovarian cancerPrabir Kumar Chakraborty, Brennah Murphy, Soumyajit Banerjee Mustafi, et al.
Redox Biology|November 10, 2023
A role for the cystathionine-β-synthase /H<sub>2</sub>S axis in astrocyte dysfunction in the aging brainAnindya Dey, Pijush Kanti Pramanik, Shailendra Kumar Dhar Dwivedi, et al.
Molecular Cancer Therapeutics|July 21, 2018
Inhibition of BMI1, a Therapeutic Approach in Endometrial CancerMegan Buechel, Anindya Dey, Shailendra Kumar Dhar Dwivedi, et al.
Molecular Cancer Therapeutics|November 22, 2017
Evaluating the Mechanism and Therapeutic Potential of PTC-028, a Novel Inhibitor of BMI-1 Function in Ovarian CancerAnindya Dey, Xunhao Xiong, Aleia Crim, et al.
EMBO Reports|August 28, 2020
MicroRNA-195 controls MICU1 expression and tumor growth in ovarian cancerGeeta Rao, Shailendra Kumar Dhar Dwivedi, Yushan Zhang, et al.
Materials Today (Kidlington, England)|October 3, 2022
Disabling partners in crime: Gold nanoparticles disrupt multicellular communications within the tumor microenvironment to inhibit ovarian tumor aggressivenessYushan Zhang, Chandra Kumar Elechalawar, Wen Yang, et al.
Pageof 4